January: Minimally Invasive Office Based Phonosurgery
February: Pediatric Ear, Nose & Throat
|
DECEMBER 2011
Temporal Bone Dissection Course
FEBRUARY 2012
Charleston Sleep Surgery Symposium
MARCH 2012
Pediatric Audiology Conference
APRIL 2012
Emerging Controversies in the Management of Thyroid and Parathyroid Disease
Sinus Masters
MAY 2012
Temporal Bone Dissection Course
Southern States Rhinology
Charleston Magnolia Conference
musc.edu/ent/cme/
|
Have questions, answers, input? Let us hear from you!
We welcome your feedback on our newsletter articles as well as any ENT questions you may have. If there are topics you are interested in learning more about, please email us at entupdate@musc.edu.
|
|
Greetings!
Happy Holidays! Our December issue of the MUSC ENT E-Update, features Director of Audiology, Kimberly A. Orr, Au.D., CCC-A, explaining the significance of early detection and intervention for hearing impaired children.
Dr. Orr and the Department's Audiology Division will be hosting an educational course in March 2012, The 3rd Annual MUSC Pediatric Audiology Conference: Auditory Neuropathy Spectrum Disorder. These courses have been well-attended and have received very favorable participant reviews.
We appreciate your continued support. Please feel free to contact us with your input or questions about our current clinical trials, your patients, or any other ENT issues at entupdate@musc.edu.
Paul R. Lambert, MD
Professor and Chair
|
Current Management Strategies for Hearing Impaired Children
 Established in 1969, the Joint Committee on Infant Hearing (JCIH) is comprised of representatives from audiology, otolaryngology, pediatrics, and nursing. The Committee publishes recommendations in the form of position statements related to newborn hearing screening and follow up. The JCIH 2007 position statement endorses early detection and intervention in an effort to maximize linguistic ability and literacy development for hearing impaired children. Delays in identification of hearing loss may result in lower educational and employment levels in adulthood. This position statement includes an expanded definition from congenital permanent bilateral, unilateral sensory, or permanent conductive hearing loss to include neural hearing loss such as auditory neuropathy spectrum disorder.
Hearing loss is the most common of the birth conditions that are typically screened for at birth (Figure 1). Hospitals in SC with 100 or more deliveries per year are mandated to screen hearing of all newborns. The birth hospital should ensure the results of the screening are conveyed to the parents and the medical home. Failure of hospital screenings in one or both ears necessitates an outpatient rescreening before one month of age. Rescreens should consist of Auditory Brainstem Response (ABR) to avoid failure to diagnose auditory neuropathy spectrum disorder and both ears should be screened, regardless of the initial screen results. For those infants who fail the rescreen, a comprehensive audiological evaluation should be completed by 3 months of age, including frequency specific air and bone conducted ABR. Infants with confirmed hearing loss should receive appropriate intervention by 6 months of age from healthcare and education professionals with expertise in hearing loss and deafness in infants and young children. Only audiologists with skills and expertise in evaluation of infants and young children with hearing loss should provide auditory habilitation services, including selection and fitting of amplification.
 |
Figure 1. Source: http://www.infanthering.org
|
Infants who are readmitted within the first month of life and have a condition associated with potential hearing loss (eg, hyperbilirubinemia that requires exchange transfusion or culture-positive sepsis) should be rescreened prior to discharge. Re-evaluations for children with risk factors should be customized depending on the likelihood of a subsequent delayed-onset hearing loss. Children with cytomegalovirus (CMV) infection, syndromes associated with hearing loss, neurodegenerative disorders, trauma, certain culture-positive infections, those who have received extracorporeal membrane oxygenation (ECMO), chemotherapy or a family history of hearing loss should be evaluated as often as every three months for a period of two years. An otolaryngologist who has knowledge of pediatric hearing loss should evaluate every infant with confirmed hearing loss. These infants should also have at least one evaluation to assess visual acuity by an ophthalmologist, who is experienced in evaluating infants. All families of infants with permanent hearing loss should be considered eligible for early intervention services. Both home-based and center-based intervention options should be offered. Infant's developmental milestones, auditory skills, parental concerns and middle ear status should be monitored in the medical home, consistent with the American Academy of Pediatrics (AAP) periodicity schedule. Infants and children whose parent's opt for amplification should be fit with appropriate hearing aids within a month of the diagnosis. Behind-the-ear (BTE) hearing aids must be sturdy, dependable, and flexible, should a change in hearing status be documented. Compatible technology such as Bluetooth and FM should be considered during the selection of the hearing aids. For those who cannot be fit with traditional hearing aids due to a permanent, conductive hearing loss (atresia, draining ears), a BAHA (osseointegrated cochlear stimulator), including an implanted abutment or softband option for those below the age of 5, should be considered. BAHA is also a good option for those with permanent, single-sided deafness.
Hearing aids should be fit utilizing appropriate verification measures, including real-ear-to-coupler difference (RECD) to ensure precise amplification, as infants and children have much smaller ear canals than adults. Children with hearing loss should have a comprehensive speech and language evaluation immediately following the diagnosis of hearing loss and should receive intensive therapy such as Auditory Verbal Therapy (AVT) on a consistent basis. Cochlear implantation should be considered for those children with severe to profound hearing loss who are not progressing with speech and language development, despite intensive therapy with parental involvement, and who demonstrate aided hearing thresholds below the range of audibility. Children can be implanted within the first year of life. The shorter the duration of deafness, the more likely a child is to benefit from a cochlear implant and develop spoken language similar to those peers with normal hearing. Children with any degree of hearing impairment should have adequate access to auditory information in their educational settings and require the expertise of an educational audiologist. Students requiring special services are supported under the Individuals with Disabilities Education Act (IDEA, 2004) or section 504 of the Rehabilitation Act (1973). References: Year 2007 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs. Joint Committee on Infant Hearing. Journal of the American Academy of Pediatrics. Vol. 120, No. 4, 2007 Kimberly A Orr, AuD Director, Division of Audiology
|
|
Kimberly A. Orr, AuD, CCC-A
Assistant Professor
Director, Audiology
MA: Ohio State University
AuD: A.T. Still University
Special interest: Identification, habilitation,
and management of hearing impaired
infants and children
Read more about Dr. Orr
|
|
|
|